This inventor holds 81 USPTO granted patents and 10 published patent applications, plus 15 CIPO patents and 27 EPO patents, primarily in Metalloenzyme Inhibitors (CPC class C07D401-06). Top assignees: Viamet Pharmaceuticals, Inc., Mycovia Pharmaceuticals, Inc., Ortho-Mcneil Pharmaceutical Corp.. Active years: 1998-2025.
Inventors with similar research interests:
Location History:
- Bryn Mawr, PA (US) (1998)
- Villanova, PA (US) (2000 - 2001)
- Chapel Hill, NC (US) (2002 - 2014)
- Durham, NC (US) (2008 - 2022)
Company Filing History:
23 out of 23 
21 out of 21 
15 out of 363 
Years Active: 1998-2025
Areas of Expertise:
Title: Innovator Spotlight: William Joel Hoekstra
Introduction: William Joel Hoekstra is a prolific inventor based in Durham, NC, with an impressive track record of 80 patents to his name. His groundbreaking work in the field of metalloenzyme inhibitors and antifungal compounds has led to significant advancements in the treatment of various diseases and disorders.
Latest Patents: Among his latest patents, William Joel Hoekstra has developed innovative metalloenzyme inhibitor compounds. These compounds exhibit metalloenzyme modulating activity and offer new methods for treating diseases and symptoms associated with such enzymes. Additionally, his work on antifungal compounds, particularly inhibitors of metalloenzymes like lanosterol demethylase (CYP51), represents a crucial development in the fight against fungal infections.
Career Highlights: Throughout his career, William Joel Hoekstra has made valuable contributions to companies like Viamet Pharmaceuticals, Inc., and Mycovia Pharmaceuticals, Inc. His expertise in the field of pharmaceuticals and drug development has been instrumental in bringing novel treatments to market and improving patient outcomes.
Collaborations: William Joel Hoekstra has collaborated with industry experts such as Christopher M Yates and Robert J Schotzinger. These collaborations have paved the way for innovative research projects and the development of cutting-edge pharmaceutical solutions.
Conclusion: In conclusion, William Joel Hoekstra stands out as a visionary inventor whose relentless pursuit of innovation has led to remarkable advancements in the field of drug development. His contributions to the development of metalloenzyme inhibitors and antifungal compounds continue to make a positive impact on healthcare and hold great promise for the future of medicine.